Verapamil Hydrochloride

Product NDC: 50090-0156
11-digit product format: 500900156
Labeler code: 50090
Product ID: 50090-0156_5ed6f578-0a48-4ffe-9510-eb971b57ff1d
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: VERAPAMIL HYDROCHLORIDE
Dosage form: TABLET
Route: ORAL
Labeler: A-S Medication Solutions
Application: ANDA071881
Marketing category: ANDA
Marketing start: 2011-01-07
Marketing end: 0000-00-00
Substance: VERAPAMIL HYDROCHLORIDE
Active strength: 120 mg/1
Pharmacologic classes: P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 2021-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	50090-0156		I	Inactivated by FDA	2026-08-03
excluded package	package	50090-0156	50090-0156-0	I	Inactivated by FDA	2026-08-03
excluded package	package	50090-0156	50090-0156-2	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 42 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0156-2	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0156-0	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0156-2	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0156-0	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0156-2	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0156-0	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0156-2	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0156-0	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0156-2	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0156-0	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0156-2	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0156-0	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0156-2	D	Discontinued by firm	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0156-0	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0156-2	D	Discontinued by firm	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0156-0	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0156-2	D	Discontinued by firm	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0156-0	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-0156-2	D	Discontinued by firm	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-0156-0	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-0156-2	D	Discontinued by firm	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-0156-0	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-0156-2	D	Discontinued by firm	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-0156-0	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50090-0156-0	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50090-0156-0	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50090-0156-0	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A071881-001	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05
A071881-002	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14
A071881-003	VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
A071881-001	AB
A071881-002	AB
A071881-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A071881-002	VERAPAMIL HYDROCHLORIDE	40MG	TABLET / ORAL	AB		2015-10-14	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A071881-003	VERAPAMIL HYDROCHLORIDE	80MG	TABLET / ORAL	AB		1988-04-05	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A071881-001	VERAPAMIL HYDROCHLORIDE	120MG	TABLET / ORAL	AB	RS	1988-04-05	`8072bd15b7f6…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A071881-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A071881-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A071881-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071881-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071881-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A071881-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A071881-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A071881-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A071881-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071881-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071881-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A071881-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071881-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071881-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A071881-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071881-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071881-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A071881-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071881-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071881-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A071881-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071881-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071881-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A071881-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071881-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071881-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A071881-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A071881-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A071881-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A071881-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071881-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071881-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A071881-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A071881-001	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A071881-002	AB	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A071881-003	AB	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A071881-001	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A071881-002	AB	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A071881-003	AB	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A071881-001	AB	1	`8072bd15b7f6…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
ea1f6fc8-bfc2-4421-a2eb-4e87c7c3e3c4	Product name	2	20230103
33ad674d-d105-6aa5-02fa-95ae4329b8cd	Product name	2	20180809
3279bd6d-5b02-e60b-3857-c853a2deb2dd	Product name	2	20170713
8ebb66e3-d7b3-f1e5-88aa-3369e64bb84a	Product name	1	20140508
940a1faa-2df8-cc65-be37-1b97984b4ea3	Product name	1	20140508
d3b67bc2-0e96-e3ec-06a9-90afcc07bf13	Product name	1	20140508
e2fcd66c-a043-3187-790d-b0342deb1149	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-0156-0	2023-01-30	C162847	48780-1	f386c649-9cf4-0266-e053-dadaa90a7c1a	Verapamil Hydrochloride Tablets, USP These highlights do not include all the information needed to use VERAPAMIL HYDROCHLORIDE safely and effectively. See full prescribing information for VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE) TABLET for ORAL use. Initial U.S. Approval:
50090-0156-2	2023-01-30	C162847	48780-1	f386c649-9cf4-0266-e053-dadaa90a7c1a	Verapamil Hydrochloride Tablets, USP These highlights do not include all the information needed to use VERAPAMIL HYDROCHLORIDE safely and effectively. See full prescribing information for VERAPAMIL HYDROCHLORIDE VERAPAMIL HYDROCHLORIDE (VERAPAMIL HYDROCHLORIDE) TABLET for ORAL use. Initial U.S. Approval:

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-0156-0	Verapamil Hydrochloride	100 in 1 BOTTLE	TABLET	100		11
50090-0156-2	Verapamil Hydrochloride	30 in 1 BOTTLE	TABLET	30		11

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-0156-0	EA - Each	50090-0156	0f52b56e-c068-44d3-a250-0f2389c169b4	1	2018-08-13
50090-0156-2	EA - Each	50090-0156	e181ad03-159d-4f61-9676-02fda0695227	1	2018-08-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
VERAPAMIL HYDROCHLORIDE	ACTIVE INGREDIENT	V3888OEY5R	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
VERAPAMIL	ACTIVE MOIETY	CJ0O37KU29	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
DIBASIC CALCIUM PHOSPHATE DIHYDRATE	INACTIVE INGREDIENT	O7TSZ97GEP	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
HYPROMELLOSE 2910 (6 MPA.S)	INACTIVE INGREDIENT	0WZ8WG20P6	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
MINERAL OIL	INACTIVE INGREDIENT	T5L8T28FGP	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
SODIUM LAURYL SULFATE	INACTIVE INGREDIENT	368GB5141J	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-0156	VERAPAMIL HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS]	11	Legacy NDC, 2 package rows	20200121_05d865d6-0582-46f1-a1fc-6df60d70b93c.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 11 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	AvKARE	a32f346e-71cf-cc11-e053-2a95a90ae88c	2026-01-15	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Northwind Health Company, LLC	f2f059a1-0cf9-a5d6-e053-2a95a90a3dab	2026-01-01	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Chartwell RX, LLC	ebc9a09a-7b5f-4df6-ace7-31185d469b28	2025-12-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Preferred Pharmaceuticals Inc.	c7a54ee0-80c0-4c7e-a6a3-cb60142f860c	2025-10-02	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Golden State Medical Supply, Inc.	3283bba6-05dd-3766-e063-6394a90ada69	2025-04-11	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	fe0583bf-9986-e01e-e053-6294a90a0b26	2025-02-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Bryant Ranch Prepack	660a83a9-60be-42d5-bc70-fe384e93beaa	2024-10-24	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	NuCare Pharmaceuticals,Inc.	7b321aa1-1b53-26d5-e053-2991aa0a1373	2024-06-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Bryant Ranch Prepack	d4a6c046-81fe-4b2a-9cb0-adb3f037eec7	2024-01-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	A-S Medication Solutions	f00c1caf-68b6-40c1-a1fa-72d17d2cf44f	2023-05-04	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881
VERAPAMIL HYDROCHLORIDE	VERAPAMIL HYDROCHLORIDE	Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.	ed1e0c14-3571-43f9-88fc-5a4d2b598263	2022-03-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 071881 application number: ANDA071881

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V3888OEY5R	VERAPAMIL HYDROCHLORIDE	152-11-4	VERAPAMIL HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
897666	verapamil HCl 120 MG Oral Tablet	PSN	05d865d6-0582-46f1-a1fc-6df60d70b93c	11
897666	verapamil hydrochloride 120 MG Oral Tablet	SCD	05d865d6-0582-46f1-a1fc-6df60d70b93c	11

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-0156-0	50090015600	100 TABLET in 1 BOTTLE (50090-0156-0)	100 tablet	2014-11-28	0000-00-00	No	No	Current
50090-0156-2	50090015602	30 in 1 BOTTLE						Historical